Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study
Abstract Aim Muscular dystrophy (MD) is a progressive disease with predominantly muscular symptoms. Myotonic dystrophy type II (MD2) and facioscapulohumeral muscular dystrophy type 1 (FSHD1) are gaining an increasing awareness, but data on cardiac involvement are conflicting. The aim of this study w...
Guardado en:
Autores principales: | Edyta Blaszczyk, Carolin Lim, Peter Kellman, Luisa Schmacht, Jan Gröschel, Simone Spuler, Jeanette Schulz-Menger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02def748032d443ba1a9fcc0f36017b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy
por: Thiéry De Serres-Bérard, et al.
Publicado: (2021) -
Distrofia muscular facioescapulohumeral en Chile: presentación de serie en hospital de referencia terciario
por: Cea,Gabriel, et al.
Publicado: (2015) -
Temporomandibular Joint Magnetic Resonance Imaging Analysis in Adults with Steinert's Myotonic Dystrophy
por: Guimarães,Antonio Sergio, et al.
Publicado: (2013) -
Epigenetics of Myotonic Dystrophies: A Minireview
por: Virginia Veronica Visconti, et al.
Publicado: (2021) -
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
por: Jie Liu, et al.
Publicado: (2021)